Jeffrey Tang

Jeffrey Tang

Auto-generated profile, based on publicly available information

Jeffrey Tang

Department of Anesthesiology, Pharmacology & Therapeutics, The University of British Columbia, Vancouver, Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2019 in Blood
Verified
Journal Article
Open access
PDF file
LHLaura K. Hilton
Laura K. Hilton
JTJeffrey Tang
Jeffrey Tang
SBSusana Ben-Neriah
Susana Ben-Neriah
MAMiguel Alcaide
Miguel Alcaide
AJAixiang Jiang
Aixiang Jiang
RMRyan D. Morin
Ryan D. Morin
High-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements (HGBL-DH/THs) include a group of diffuse large B-cell lymphomas (DLBCLs) with inferior outcomes after standard chemoimmunotherapy. We recently described a gene expression signature that identifies 27% of germinal center B-cell DLBCLs (GCB-DLBCLs) as having a double-hit–like expression pattern (DHITsig) and inferior outcomes; however, only half of these cases have both MYC and BCL2 translocations identifiable using standard breakapart fluorescence in situ hybridization (FISH). Here, 20 DHITsig+ GCB-DLBCLs apparently lacking MYC and/or BCL2 rearrangements underwent whole-genome sequencing. This revealed 6 tumors with MYC or BCL2 rearrangements that were cryptic to breakapart FISH. Copy-number analysis identified 3 tumors with MYC and 6 tumors with MIR17HG gains or amplifications, both of which may contribute to dysregulation of MYC and its downstream pathways. Focal deletions of the PVT1 promoter were observed exclusively among DHITsig+ tumors lacking MYC translocations; this may also contribute to MYC overexpression. These results highlight that FISH fails to identify all HGBL-DH/THs, while revealing a range of other genetic mechanisms potentially underlying MYC dysregulation in DHITsig+ DLBCL, suggesting that gene expression profiling is more sensitive for identifying the biology underlying poor outcomes in GCB-DLBCL.

1 November 2020 in Blood Cancer Discovery
Verified
Journal Article
Closed access
PDF file
AJAixiang Jiang
Aixiang Jiang
LHLaura K. Hilton
Laura K. Hilton
JTJeffrey Tang
Jeffrey Tang
CRChristopher K. Rushton
Christopher K. Rushton
BGBruno M. Grande
Bruno M. Grande
RMRyan D. Morin
Ryan D. Morin
Gene expression classifiers are gaining increasing popularity for stratifying tumors into subgroups with distinct biological features. A fundamental limitation shared by current classifiers is the requirement for comparable training and testing datasets. Here, we describe a self-training implementation of our probability ratio-based classification prediction score method (PRPS-ST), which facilitates the porting of existing classification models to other gene expression datasets. In comparison with gold standards, we demonstrate favorable performance of PRPS-ST in gene expression–based classification of diffuse large B-cell lymphoma (DLBCL) and B-lineage acute lymphoblastic leukemia (B-ALL) using a diverse variety of gene expression data types and preprocessing methods, including in classifications with a high degree of class imbalance. Tumors classified by our method were significantly enriched for prototypical genetic features of their respective subgroups. Interestingly, this included cases that were unclassifiable by established methods, implying the potential enhanced sensitivity of PRPS-ST. Significance: The adoption of binary classifiers such as cell of origin (COO) has been thwarted, in part, by the challenges imposed by batch effects and continual evolution of gene expression technologies. PRPS-ST resolves this by enabling classifiers to be ported across platforms while retaining high accuracy. This article is highlighted in the In This Issue feature, p. 215

4 April 2023
Verified
Other
Open access
AJAixiang Jiang
Aixiang Jiang
LHLaura K. Hilton
Laura K. Hilton
JTJeffrey Tang
Jeffrey Tang
CRChristopher K. Rushton
Christopher K. Rushton
BGBruno M. Grande
Bruno M. Grande
RMRyan D. Morin
Ryan D. Morin
Gene expression classifiers are gaining increasing popularity for stratifying tumors into subgroups with distinct biological features. A fundamental limitation shared by current classifiers is the requirement for comparable training and testing datasets. Here, we describe a self-training implementation of our probability ratio-based classification prediction score method (PRPS-ST), which facilitates the porting of existing classification models to other gene expression datasets. In comparison with gold standards, we demonstrate favorable performance of PRPS-ST in gene expression–based classification of diffuse large B-cell lymphoma (DLBCL) and B-lineage acute lymphoblastic leukemia (B-ALL) using a diverse variety of gene expression data types and preprocessing methods, including in classifications with a high degree of class imbalance. Tumors classified by our method were significantly enriched for prototypical genetic features of their respective subgroups. Interestingly, this included cases that were unclassifiable by established methods, implying the potential enhanced sensitivity of PRPS-ST.Significance:The adoption of binary classifiers such as cell of origin (COO) has been thwarted, in part, by the challenges imposed by batch effects and continual evolution of gene expression technologies. PRPS-ST resolves this by enabling classifiers to be ported across platforms while retaining high accuracy.This article is highlighted in the In This Issue feature, p. 215


23 September 2026 in Matrix Biology
Verified
Journal Article
Open access
AAAlexandre Aubert
Alexandre Aubert
APAnna Prudova
Anna Prudova
JTJeffrey S. Tang
Jeffrey S. Tang
JSJhunam Sidhu
Jhunam Sidhu
HAHans H. Adomat
Hans H. Adomat
DGDavid James Granville
David James Granville

11 September 2026 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
KRKatlyn C. Richardson
Katlyn C. Richardson
JTJeffrey S. Tang
Jeffrey S. Tang
AAAlexandre Aubert
Alexandre Aubert
RCRichard I. Crawford
Richard I. Crawford
ASAmrit Singh
Amrit Singh
DGDavid James Granville
David James Granville
Granzymes (Gzms) are a family of serine proteases that have been traditionally studied as cytotoxic mediators of lymphocyte-mediated target cell death. However, increasing evidence suggests that during inflammation Gzms can accumulate in the extracellular milieu and contribute to various pathologies depending on the Gzm. While much work has been done with respect to elucidating the extracellular impact of GzmB, less is understood for other Gzms. Recently, a role for extracellular GzmK was proposed for a number of pro-inflammatory and/or autoimmune conditions, including psoriasis. In order to further delineate a mechanistic role for GzmK in psoriasis, a transcriptomic approach was used to assess the impact of extracellular GzmK on cell signalling. Extracellular GzmK induced a temporally structured program of epithelial reprograming characterized by early activation of nucleotide biosynthesis, followed by proliferative commitment and induction of structural differentiation genes despite suppression of lipid biosynthesis. Mechanistically, GzmK selectively activated de novo purine biosynthesis at the level of the rate-limiting enzyme PPAT, and inhibition upstream of this pathway abrogated GzmK-driven hyperproliferation, identifying nucleotide availability as a limiting determinant of epithelial expansion. Integration with human psoriatic transcriptome, validation in patient tissues, and analysis in a murine model demonstrate that these programs are GzmK-dependent and relevant to human disease. Together, these findings define a non-canonical function of an immune protease linking inflammatory cues to epithelial metabolism and reprogramming.